Literature DB >> 25050807

HMGB1 gene polymorphism is associated with hypertension in Han Chinese population.

Yingshui Yao1, Daoxia Guo, Song Yang, Yuelong Jin, Lianping He, Jinfeng Chen, Xianghai Zhao, Yanchun Chen, Wei Zhou, Chong Shen.   

Abstract

BACKGROUND: High-mobility group box 1 protein (HMGB1) acts as a proinflammatory cytokine by activating pattern recognition receptors (PRRs), including Toll-like receptor 4 (TLR4) and the receptor of AGE (AGER) with oxidative injury. Animal study proved that HMGB1 contributed to the pathogenesis of experimental pulmonary hypertension (HT) via activation of TLR4. The aim of this study is to test whether HMGB1 harbor genetic susceptibility to HT in a Chinese population.
METHODS: A case-control study comprising 2012 HT cases and 2210 controls was used to evaluate the association of three tagging single nucleotide polymorphism (tagSNPs) in HMGB1 gene with HT and blood pressure. Logistic regression model was used to adjust confounding factor for HT and general linear model (GLM) was applied to compare blood pressure levels between genotypes in cases and controls.
RESULTS: Single locus analysis showed that there was no statistical association of three tagSNPs with HT after adjustment for the covariates. Further stratification analysis found that rs2249825 was significantly associated with HT in ≥55 years groups, ORs (95% CI) of additive model and dominant model were 1.208 (1.029-1.417) and 1.212 (1.020-1.441), and p values were 0.021 and 0.029, respectively. Quantitative trait analysis indicated that DBP had a linear decrease with the variations of rs2249825 in both untreated HT group (p=0.002) and control group (p=0.034) respectively.
CONCLUSIONS: Our finding suggests that rs2249825 of HMGB1 genetic polymorphisms are significantly associated with HT and diastolic blood pressure, and the genetic effect on HT is modulated by age.

Entities:  

Keywords:  Association study; HMGB1; hypertension

Mesh:

Substances:

Year:  2014        PMID: 25050807     DOI: 10.3109/10641963.2014.933963

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  8 in total

Review 1.  Immunity in arterial hypertension: associations or causalities?

Authors:  Hans-Joachim Anders; Marcus Baumann; Giovanni Tripepi; Francesca Mallamaci
Journal:  Nephrol Dial Transplant       Date:  2015-03-11       Impact factor: 5.992

2.  High mobility group box 1 protein polymorphism affects susceptibility to recurrent pregnancy loss by up-regulating gene expression in chorionic villi.

Authors:  Hua Jin; Jie Wu; Qiuhong Yang; Yan Cai; Wenxiu He; Cuiying Liu
Journal:  J Assist Reprod Genet       Date:  2015-05-10       Impact factor: 3.412

3.  Obesity-associated hypertension is ameliorated in patients with TLR4 single nucleotide polymorphism (SNP) rs4986790.

Authors:  Simon Schneider; Marcus Baumann; Petra Hoppmann; Werner Koch; Stephan Kemmner; Christoph Schmaderer; Lutz Renders; Adnan Kastrati; Karl-Ludwig Laugwitz; Uwe Heemann
Journal:  J Inflamm (Lond)       Date:  2015-10-01       Impact factor: 4.981

Review 4.  Metabolic Syndrome and Autophagy: Focus on HMGB1 Protein.

Authors:  Vincenza Frisardi; Carmela Matrone; Maria Elisabeth Street
Journal:  Front Cell Dev Biol       Date:  2021-04-12

5.  Genetic predisposition to ischaemic stroke by RAGE and HMGB1 gene variants in Chinese Han population.

Authors:  You Li; Jing Zhu; Linfa Chen; Weidong Hu; Mengxu Wang; Shengnan Li; Xuefeng Gu; Hua Tao; Bin Zhao; Guoda Ma; Keshen Li
Journal:  Oncotarget       Date:  2017-10-26

Review 6.  HMGB1: A Possible Crucial Therapeutic Target for COVID-19?

Authors:  Maria Elisabeth Street
Journal:  Horm Res Paediatr       Date:  2020-05-06       Impact factor: 2.852

7.  Abnormal Endothelial Gene Expression Associated With Early Coronary Atherosclerosis.

Authors:  Robert P Hebbel; Peng Wei; Liming Milbauer; Michel T Corban; Anna Solovey; James Kiley; Jack Pattee; Lilach O Lerman; Wei Pan; Amir Lerman
Journal:  J Am Heart Assoc       Date:  2020-07-16       Impact factor: 5.501

8.  The Impact of HMGB1 Polymorphisms on Prostate Cancer Progression and Clinicopathological Characteristics.

Authors:  Ying-Erh Chou; Po-Jen Yang; Chia-Yen Lin; Yen-Yu Chen; Whei-Ling Chiang; Pei-Xuan Lin; Zih-Yun Huang; Matthew Huang; Yung-Chuan Ho; Shun-Fa Yang
Journal:  Int J Environ Res Public Health       Date:  2020-10-03       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.